Difficulty: Medium
Average Score: 91%
Practice
The only inhaler corticosteroid (ICS) with FDA-approved labeling for children
Correct answer
B
Rationale
The correct answer is B) budesonide nebulizer suspension. This is the only inhaler corticosteroid with FDA-approved labeling for children <4 years of age due to its safety and efficacy profile in this age group. Budesonide is commonly used in pediatric patients for its anti-inflammatory properties and minimal systemic absorption when delivered via a nebulizer, making it a preferred choice for young children who may have difficulty using other inhaler devices.
Option A) beclomethasone HFA, option C) mometasone DPI, and option D) triamcinolone acetonide are not FDA-approved for use in children <4 years old. Beclomethasone is typically used in older children and adults, mometasone is indicated for children over 4 years old, and triamcinolone acetonide is not recommended for use in children under 6 years of age.
In pediatric nursing, it is crucial to be aware of age-specific medication guidelines to ensure safe and effective care for young patients. Understanding the FDA-approved medications for different age groups helps nurses make informed decisions when administering treatments and advocating for the best interests of pediatric patients.
Option A) beclomethasone HFA, option C) mometasone DPI, and option D) triamcinolone acetonide are not FDA-approved for use in children <4 years old. Beclomethasone is typically used in older children and adults, mometasone is indicated for children over 4 years old, and triamcinolone acetonide is not recommended for use in children under 6 years of age.
In pediatric nursing, it is crucial to be aware of age-specific medication guidelines to ensure safe and effective care for young patients. Understanding the FDA-approved medications for different age groups helps nurses make informed decisions when administering treatments and advocating for the best interests of pediatric patients.